SRPT

Sarepta Therapeutics, Inc. Press Releases

$26.22
*  
1.96
8.08%
Get SRPT Alerts
*Delayed - data as of May 22, 2015  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Sarepta Therapeutics Announces Plans to Submit Rolling NDA for Eteplirsen following Today’s Pre-NDA Meeting with the FDA
5/19/2015 4:00:00 PM - Business Wire
▲59.98 % Price Change since this news event. The Volume Ratio is 21.1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/12/2015 4:30:00 PM - Business Wire
▲72.39 % Price Change since this news event. The Volume Ratio is 0.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day